CytRx Corp. (CYTR) Gets U.S. Patent for Leukemia Treatment Bafetinib
Tweet Send to a Friend
CytRx Corporation (Nasdaq: CYTR) today announced the granting by the U.S. Patent and Trademark Office (USPTO) of U.S. Patent 7,728,131 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
